MedPath

EFFICASY OF SIDDHA FORMULATION ââ?¬Å?KANDANGAARI NEIââ?¬? IN THE MANAGEMENT OF ââ?¬Å?SWASAKAASAMââ?¬?(BRONCHIAL ASTHMA).

Phase 2
Completed
Conditions
Health Condition 1: J459- Other and unspecified asthma
Registration Number
CTRI/2021/07/035304
Lead Sponsor
ATIONAL INSTITUTE OF SIDDHA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Age between 18-60 years.

Sex: Male, Female & Transgender.Patients with a clinical symptoms of Sneezing, Rhinitis, Dyspnoea, Cough with or without expectoration, Wheeze, Tightness of chest.

Wheezing more than 3 weeks.

Night time wheezing more than one day/week.

Asthma sometimes interferes with normal daily activities.

Status asthmaticus

Patients who are willing to take radiological investigation and provide blood for lab investigation.

Patients who are willing to estimate volume of air forcibly expired after a deep inspiration by using PFT.

Exclusion Criteria

Tuberculosis

Restrictive lung disease

COPD

Emphysema

Pleural effusion

Cardiac disease

Renal disease

Diabetic mellitus

Symptoms of acute severe illness like Chest pain, nausea, vomiting, high fever, dyspnea

Recent haemoptysis

Pneumothorax

Recent history of abdominal, thoracic, or cerebral aneurysm

Anaemia

Sleep apnoea

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath